Blau

CONTENTS
DiePharmazie 12/2017

 

Original articles

Yuanyuan Hu, Wenchen Ruan, Anhui Gao, Yubo Zhou, Lixin Gao, Meng Xu, Jianrong Gao, Qing Ye, Jia Li, Tao Pang: Synthesis and biological evaluation of novel 4,5-bisindolyl-1,2,4-triazol-3-ones as glycogen synthase kinase-3β inhibitors and neuroprotective agents
doi: 10.1691/ph.2017.7722 (pp. 707-713)

 

Zacchigna M, Cateni F, Procida G, Zampieri D, Mamolo MG: PEGylation of coenzyme Q10 and in vitro release studies
doi: 10.1691/ph.2017.7706 (pp. 714-720)

 

Gonçalez ML, Rigon RB, Pereira-da-Silva MA, Chorilli M: Curcumin-loaded cationic solid lipid nanoparticles as a potential platform for the treatment of skin disorders
doi: 10.1691/ph.2017.7101 (pp. 721-727)

 

Ding Y, Pyo SM, Müller RH: smartLipids® as 3rd solid lipid nanoparticle generation – stabilization of retinol for dermal application
doi: 10.1691/ph.2017.7016 (pp. 728-735)

 

Katsai OG, Ruban OA, Krasnopolskyi YM: Preparation and in-vivo evaluation of cytochrome-C-containing liposomes
doi: 10.1691/ph.2017.7072 (pp. 736-740)

 

Curti C, Lamy E, Primas N, Fersing C, Jean C, Bertault-Peres P, Vanelle P: Stability studies of five anti-infectious eye drops under exhaustive storage conditions
doi: 10.1691/ph.2017.7089 (pp. 741-746)

 

Miyata-Nozaka Y, Mohd Zain S, Taguchi M, Shigeyama M, Isobe T, Hanioka N: Carbamazepine 10,11-epoxidation in human liver microsomes: influence of the CYP3A5*3 polymorphism
doi: 10.1691/ph.2017.7754 (pp. 747-750)

 

Ruzickova E, Janska R, Dolezel P, Mlejnek P: Clinically relevant interactions of anti-apoptotic Bcl-2 protein inhibitors with ABC transporters
doi: 10.1691/ph.2017.7696 (pp. 751-758)

 

Shaojun Su, Xinguang Nie: MiR-139 prompts the development of osteosarcomas mainly through targeting ROCK1
doi: 10.1691/ph.2017.7439 (pp. 759-763)

 

Botermann L, Wachter A, Monzel K, Krueger K, Ewen S, Mahfoud F, Griese-Mammen N, Schulz M, Laufs U: Do patients with diabetes type 2 or chronic heart failure understand a medication plan?
doi: 10.1691/ph.2017.7773 (pp. 764-768)

 


Impressum


Zurück